{"result": "(\"entity\"<|>DRFQ<|>EVENT<|>DRFQ refers to a specific type of diabetes diagnosed in patients, requiring treatment and management strategies such as insulin and nutritional education.)\n##\n(\"entity\"<|>INSULINA<|>ORGANIZATION<|>Insulina is a hormone used as the primary treatment for DRFQ, helping to control blood glucose levels in patients.)\n##\n(\"entity\"<|>NE<|>ORGANIZATION<|>NE refers to nutritional supplements administered to patients, particularly those with specific dietary needs due to conditions like DRFQ.)\n##\n(\"entity\"<|>FQ<|>EVENT<|>FQ refers to a condition that can lead to complications such as malnutrition, affecting the treatment and management of patients.)\n##\n(\"entity\"<|>PACIENTE<|>PERSON<|>The patient is an individual diagnosed with DRFQ, undergoing treatment and management for their condition.)\n##\n(\"entity\"<|>EDUCACIÓN NUTRICIONAL<|>ORGANIZATION<|>Educación nutricional is a crucial component of managing DRFQ, focusing on dietary habits and nutritional intake.)\n##\n(\"entity\"<|>GASTROSTOMÍA<|>EVENT<|>Gastrostomía is a medical procedure indicated for patients with FQ who have low BMI or significant weight loss, allowing for nutritional support.)\n##\n(\"relationship\"<|>PACIENTE<|>DRFQ<|>The patient has been diagnosed with DRFQ, which requires specific treatment and management strategies<|>8)\n##\n(\"relationship\"<|>PACIENTE<|>INSULINA<|>The patient is being treated with insulin to manage their DRFQ<|>9)\n##\n(\"relationship\"<|>PACIENTE<|>NE<|>The patient is receiving nutritional supplements (NE) to support their dietary needs<|>7)\n##\n(\"relationship\"<|>PACIENTE<|>EDUCACIÓN NUTRICIONAL<|>The patient is undergoing nutritional education to improve their dietary habits and manage their condition<|>8)\n##\n(\"relationship\"<|>PACIENTE<|>GASTROSTOMÍA<|>The patient has undergone gastrostomy due to low BMI and weight loss, indicating a need for nutritional support<|>6)\n##\n(\"relationship\"<|>DRFQ<|>INSULINA<|>Insulin is the primary treatment for managing DRFQ<|>9)\n##\n(\"relationship\"<|>DRFQ<|>EDUCACIÓN NUTRICIONAL<|>Nutritional education is essential for managing DRFQ effectively<|>8)\n##\n(\"relationship\"<|>FQ<|>PACIENTE<|>The patient is affected by FQ, which complicates their nutritional status and treatment<|>7)\n##\n(\"relationship\"<|>FQ<|>GASTROSTOMÍA<|>Gastrostomy is indicated for patients with FQ who have low BMI or significant weight loss<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: Q se recomienda realizar una sobrecarga oral con 75g de glucosa de forma anual a todos los pacientes a partir de los 10 años. También se puede medir glucemia basal y 2h postprandial en caso de estrés o empleo de glucocorticoides o durante la NE. Los criterios diagnósticos de DRFQ se recogen en la Tabla 2.\n\nEl tratamiento de elección de la DRFQ es la insulina junto con una buena educación nutricional y ejercicio aeróbico regular. El papel de los hipoglucemiantes orales es controvertido, si bien se ha publicado recientemente que la repaglinida es igual de segura y eficaz que la insulina en pacientes con DRFQ de reciente diagnóstico⁴.\n\n123\n---\nEn el caso de nuestro paciente, el diagnóstico de DRFQ se había realizado a los 14 años, 3 años antes de ser remitido a nuestras consultas. Desde el inicio estaba insulinizado con una insulina basal, pero presentaba un mal control glucémico de forma habitual. Dado el escaso tiempo de evolución, aún no presentaba complicaciones crónicas derivadas de la diabetes.\n\nDentro del tratamiento de la DRFQ, es esencial una buena educación nutricional y ejercicio aeróbico regular, como base del tratamiento. Así, durante la evolución en nuestras consultas, el control glucémico se ha visto influido en gran medida por el aporte de NE nocturnas y las diferentes fórmulas de NE administradas. Cuando se realizó el cambio a una fórmula de NE peptídica, rica en triglicéridos de cadena media, para mejorar la esteatorrea, pero también rica en hidratos de carbono de absorción rápida, se produjo un empeoramiento marcado del control glucémico, que obligó a la retirada de la fórmula y reintroducción de la fórmula polimérica específica para diabéticos.\n\nPosteriormente, el control glucémico mejoró de forma progresiva, y se fue intensificando con el cambio a insulinas basales más nuevas y de mayor duración como la insulina degludec y, en las últimas visitas, la administración de la NE nocturna obligó a añadir una insulina mixta, que permitió controlar mejor la hiperglucemia nocturna relacionada con la NE. En el momento actual, ha mejorado considerablemente el control glucémico.\n\nPor otra parte, la desnutrición es otra de las complicaciones que se dan en los pacientes con FQ. Su alta prevalencia se explica por la concurrencia de diversos mecanismos: aumento del gasto energético, disminución del aporte nutricional (sobre todo en períodos de descompensación a nivel pulmonar) y malabsorción intestinal. La etiopatogenia de la desnutrición en FQ se resume en la Tabla 3⁵.\n\nEl objetivo nutricional en pacientes con FQ varía en función de la edad, recomendándose, en niños, que alcancen un IMC por encima del percentil 50 y en adultos un IMC de 22 y 23kg/m², en mujeres y hombres respectivamente. Hay que tener en cuenta que es esencial preservar la masa muscular, ya que se relaciona con la función pulmonar y la supervivencia⁶.\n\nPara la redacción del caso, a la hora de realizar el diagnóstico de desnutrición se han empleado los criterios GLIM, recientemente publicados⁷. De ellos, nuestro paciente cumplía 2 criterios fenotípicos (bajo IMC y masa muscular reducida medida mediante PMB y BCB, y 2 criterios etiológicos (alteración en la absorción y condición inflamatoria), diagnosticándose de una desnutrición calórica crónica grave.\n\nEn cuanto a los requerimientos nutricionales de los pacientes con FQ, se recomienda un aporte energético en torno al 110-200% de los requerimientos energéticos para adultos sanos de la misma edad y sexo, con una distribución de macronutrientes: hidratos de carbono: 40-45% (preferiblemente complejos con bajo índice glucémico),\n---\ngrasas: 35-40% y proteínas: 20%6. En el caso de nuestro paciente, en la 1ª visita presen-\ntaba una ingesta desordenada, por lo que se le explicó una dieta equilibrada, siendo\néste el primer escalón de tratamiento. Además, se reforzó la ingesta oral con suplementos\norales (SNO).\n\nEn cuanto a la pauta de NE por gastrostomía, se ha ido variando para adecuarse\na la situación clínica del paciente. La gastrostomía está indicada en pacientes adultos\ncon FQ que presenten un IMC bajo (IMC<18kg/m2) de forma mantenida o una pérdida de\npeso superior al 5% de forma mantenida, como era el caso de nuestro paciente. Actual-\nmente, no existe ninguna indicación clara en lo que respecta a la fórmula de elección\nde la NE\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}